DOCK10 and B-cell chronic lymphocytic leukemia: At the protein level, other authors and ourselves have provided, in previous reports, validation for several IL-4 targets detected in this study, such as CYSLTR1 [31], IGHE [32] and NFIL3 [33] in B cells, or for DOCK10 in CLL and NBC cells [34].